We showed that the VEGFR2 and ADRB2 interaction regulated downstream signaling in NSCLC cells and apatinib treatment significantly enhanced the complex formations between ADRB2 and VEGFR2. Here, ADRB2 is linked to non-small cell lung carcinoma.